Replies to post #169347 on Biotech Values

[oc631]

And if you were a GT1 treatment-naïve patient, would you take ABBV's regimen or GILD's (assuming 12 weeks treatment and SVRs are in the same ballpark)?

I'm firmly in the nuke-based camp so the GILD combo seems preferable. A large selling point for naive and experienced patients should be which combo works best in the absence of Ribavirin.